Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Beyond tyrosine kinase inhibition: promising new developments in molecular oncology
Symposium Chairs: J. Cadranel (Paris, France), M. Remmelink (Brussels, Belgium)
Aims: The goal of this symposium is to provide an overview of fundamental biological and immunological principals of lung cancer biology beyond the tyrosine kinase inhibitor-induced inhibition of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR). The mode of action of therapeutics that are being assessed currently will be presented. Skilled speakers, all of them experienced clinicians and scientists, will highlight how to translate the latest science into clinical practice with respect to the early diagnosis, prognosis and therapy of thoracic malignancies.